Business Description
Hebei Changshan Biochemical Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE1000016C2
Share Class Description:
SZSE:300255: Class ACompare
Compare
Traded in other countries / regions
300255.China IPO Date
2011-08-19Description
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 1.16 | |||||
| Debt-to-EBITDA | -1.69 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.34 | |||||
| Beneish M-Score | -3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.3 | |||||
| 3-Year FCF Growth Rate | 18.2 | |||||
| 3-Year Book Growth Rate | -13.5 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.4 | |||||
| 9-Day RSI | 38.56 | |||||
| 14-Day RSI | 40.39 | |||||
| 6-1 Month Momentum % | -13.9 | |||||
| 12-1 Month Momentum % | 103.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.4 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 729.09 | |||||
| Days Sales Outstanding | 75.68 | |||||
| Days Payable | 85.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.05 | |||||
| 3-Year Dividend Growth Rate | -27.3 | |||||
| 5-Year Yield-on-Cost % | 0.05 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 0.39 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.74 | |||||
| Operating Margin % | -44.86 | |||||
| Net Margin % | -108.61 | |||||
| FCF Margin % | 4.64 | |||||
| ROE % | -53.61 | |||||
| ROA % | -24.58 | |||||
| ROIC % | -11.92 | |||||
| ROC (Joel Greenblatt) % | -32.47 | |||||
| ROCE % | -34.73 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 233.5 | |||||
| PS Ratio | 7.12 | |||||
| PB Ratio | 4.92 | |||||
| Price-to-Tangible-Book | 8.05 | |||||
| Price-to-Free-Cash-Flow | 150.65 | |||||
| Price-to-Operating-Cash-Flow | 34.61 | |||||
| EV-to-EBIT | -8.45 | |||||
| EV-to-EBITDA | -8.45 | |||||
| EV-to-Revenue | 8.46 | |||||
| EV-to-FCF | 186.32 | |||||
| Price-to-Median-PS-Value | 1.95 | |||||
| Earnings Yield (Greenblatt) % | -11.83 | |||||
| FCF Yield % | 0.65 | |||||
| Forward Rate of Return (Yacktman) % | -13.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hebei Changshan Biochemical Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,202.834 | ||
| EPS (TTM) (Â¥) | -1.422 | ||
| Beta | 1.41 | ||
| Volatility % | 204.22 | ||
| 14-Day RSI | 40.39 | ||
| 14-Day ATR (Â¥) | 0.460701 | ||
| 20-Day SMA (Â¥) | 9.8255 | ||
| 12-1 Month Momentum % | 103.49 | ||
| 52-Week Range (Â¥) | 4.3 - 17.98 | ||
| Shares Outstanding (Mil) | 919.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hebei Changshan Biochemical Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hebei Changshan Biochemical Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hebei Changshan Biochemical Pharmaceutical Co Ltd Frequently Asked Questions
What is Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255)'s stock price today?
The current price of SZSE:300255 is ¥9.34. The 52 week high of SZSE:300255 is ¥17.98 and 52 week low is ¥4.30.
When is next earnings date of Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255)?
The next earnings date of Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255) is .
Does Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255) pay dividends? If so, how much?
The Dividend Yield %  of Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255) is 0.05% (As of Today), Highest Dividend Payout Ratio of Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255) was 2.6. The lowest was 0.05. And the median was 0.12. The  Forward Dividend Yield % of Hebei Changshan Biochemical Pharmaceutical Co Ltd(SZSE:300255) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers